This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glauber, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glauber, J. H.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Hepatitis B
Haemophilus influenzae Infections
Poliovirus Infections
PEDIATRICS Vol. 112 No. 1 July 2003, pp. e39-e45

ELECTRONIC ARTICLE

The Immunization Delivery Effectiveness Assessment Score: A Better Immunization Measure?

James H. Glauber, MD, MPH

From the Neighborhood Health Plan, Boston, Massachusetts

Background. Childhood immunization measures, such as the Health Employer Data Information Set (HEDIS) or the National Immunization Survey, assess the percentage of children up-to-date for a specified series of vaccinations. In particular, the HEDIS assesses immunization delivery to children enrolled in managed care organizations (MCO). Such measures do not assess the timeliness of immunization delivery with reference to recommended age standards. To achieve maximal protection against vaccine-preventable diseases, children should receive all immunizations within recommended age intervals—fully "on-time."

Objective. The Immunization Delivery Effectiveness Assessment (IDEA) is a novel immunization measure that assesses, on a continuous scale, the timeliness of administration of each vaccination with reference to recommended age intervals. Specifically we ask: 1) Do absolute immunization rates differ between HEDIS and IDEA? 2) Does relative MCO performance differ when assessed by the 2 performance measures? 3) How well do MCOs perform relative to the standard of fully on-time immunization? The health services implications of using the timeliness standard to assess childhood immunization delivery is discussed.

Methods. A vaccine-dose IDEA score was developed for each of the 14 vaccination events in the 4:3:1:3:3 combination series (4 diphtheria-pertussis-tetanus:3 polio:1 measles-mumps-rubella:3 Haemophilus influenzae type B:3 hepatitis B). Assessing the actual age of administration with reference to the recommended age of administration generates the vaccine-dose IDEA score. A child’s composite IDEA score is obtained by averaging the 14 vaccine-dose IDEA scores. These composite IDEA scores, when averaged among children sampled within the MCO, constitute the MCO’s immunization score.

Setting. Retrospective analysis of childhood immunization datasets from a convenience sample of 6 MCOs in 5 states.

Results. HEDIS rates ranged from 57% to 75%. IDEA scores ranged from 80% to 90%. Relative rankings of MCO immunization performance were different using HEDIS rates and IDEA scores, respectively. At most, 16% of children in any of these MCOs received all of their immunizations fully on-time. From 47% to 77% of children experienced at least 3 delayed immunizations.

Conclusions. An immunization measure based on timeliness of administration yields both absolute and relative differences in MCO childhood immunization performance when compared with HEDIS rates. By assessing delivery of each component vaccination, the IDEA score permits more detailed analysis of immunization patterns within an MCO and focuses improvement efforts.

Key Words: immunization • measurement • quality • managed care

Abbreviations: HEDIS, Health Employer Data Information Set • MCO, managed care organization • IDEA, Immunization Delivery Effectiveness Assessment • VPD, vaccine-preventable disease • NIS, National Immunization Survey • DPT, diphtheria-pertussis-tetanus • MMR, measles-mumps-rubella • HIB, Haemophilus influenzae type B • HBV, hepatitis B • AAP, American Academy of Pediatrics • ACIP, Advisory Committee on Immunization Practice • a-AOA, actual age-of-administration • DOL, days-of-life • L-AOA, latest acceptable age of administration

Received for publication Jun 12, 2002; Accepted Feb 27, 2003.




This article has been cited by other articles:


Home page
 JAMAHome page
E. T. Luman, L. E. Barker, K. M. Shaw, M. M. McCauley, J. W. Buehler, and L. K. Pickering
Timeliness of Childhood Vaccinations in the United States: Days Undervaccinated and Number of Vaccines Delayed
JAMA, March 9, 2005; 293(10): 1204 - 1211.
[Abstract] [Full Text] [PDF]